Related Experiment Video
Updated: Aug 16, 2026

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
Published on: December 1, 2023
Mammalian peptidylglycine alpha-amidating monooxygenase mRNA expression can be modulated by the La autoantigen
Fabienne Brenet1, Nadège Dussault, Jonas Borch
1Université de la Méditerranée, Aix-Marseille II, Laboratoire de Cancérologie Expérimentale, Inserm EMI 0359, Faculté de Médecine Secteur Nord, IFR Jean Roche, Marseille, France.
Abstract:
Peptidylglycine alpha-amidating monooxygenase (PAM; EC 1.14.17.3) catalyzes the COOH-terminal alpha-amidation of peptidylglycine substrates, yielding amidated products. We have previously reported a putative regulatory RNA binding protein (PAM mRNA-BP) that binds specifically to the 3' untranslated region (UTR) of PAM-mRNA. Here, the PAM mRNA-BP was isolated and revealed to be La protein using affinity purification onto a 3' UTR PAM RNA, followed by tandem mass spectrometry identification. We determined that the core binding sequence is approximately 15-nucleotides (nt) long and is located 471 nt downstream of the stop codon. Moreover, we identified the La autoantigen as a protein that specifically binds the 3' UTR of PAM mRNA in vivo and in vitro. Furthermore, La protein overexpression caused a nuclear retention of PAM mRNAs and resulted in the down-regulation of endogenous PAM activity. Most interestingly, the nuclear retention of PAM mRNA is lost upon expressing the La proteins that lack a conserved nuclear retention element, suggesting a direct association between PAM mRNA and La protein in vivo. Reporter assays using a chimeric mRNA that combined luciferase and the 3' UTR of PAM mRNA demonstrated a decrease of the reporter activity due to an increase in the nuclear localization of reporter mRNAs, while the deletion of the 15-nt La binding site led to their clear-cut cytoplasmic relocalization. The results suggest an important role for the La protein in the modulation of PAM expression, possibly by mechanisms that involve a nuclear retention and perhaps a processing of pre-PAM mRNA molecules.
Insights
The La protein binds to PAM mRNA, causing its nuclear retention and down-regulating PAM activity. This suggests La protein modulates peptidylglycine alpha-amidating monooxygenase expression through mRNA localization.
Area of Science:
- Biochemistry
- Molecular Biology
- Gene Regulation
Background:
- Peptidylglycine alpha-amidating monooxygenase (PAM) catalyzes crucial COOH-terminal alpha-amidation.
- A regulatory RNA binding protein (PAM mRNA-BP) was previously identified, binding the 3' UTR of PAM mRNA.
Purpose of the Study:
- To identify PAM mRNA-BP and elucidate its role in PAM gene expression regulation.
- To investigate the mechanism by which PAM mRNA-BP affects PAM mRNA localization and activity.
Main Methods:
- Affinity purification of PAM mRNA-BP using 3' UTR PAM RNA.
- Tandem mass spectrometry for protein identification.
- In vivo and in vitro binding assays.
- Overexpression studies and reporter assays.
Main Results:
- PAM mRNA-BP was identified as the La autoantigen.
- La protein specifically binds the 3' UTR of PAM mRNA at a 15-nt sequence.
- La protein overexpression leads to nuclear retention of PAM mRNA and reduced PAM activity.
- Reporter assays confirm La protein's role in nuclear mRNA localization and activity modulation.
Conclusions:
- La protein is a key regulator of PAM gene expression.
- Regulation occurs via nuclear retention of PAM mRNA, influenced by a specific binding site.
- La protein may also be involved in pre-PAM mRNA processing.
More Related Videos
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
10:47Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies
Published on: October 27, 2016
Related Concept Videos
Cell Specific Gene Expression
RNA Editing
TGF - β Signaling Pathway